Compare HEI & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HEI | BDX |
|---|---|---|
| Founded | 1957 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8B | 43.0B |
| IPO Year | 1995 | 1998 |
| Metric | HEI | BDX |
|---|---|---|
| Price | $371.20 | $182.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $357.08 | $186.00 |
| AVG Volume (30 Days) | 408.2K | ★ 1.7M |
| Earning Date | 05-26-2026 | 05-07-2026 |
| Dividend Yield | 0.09% | ★ 2.89% |
| EPS Growth | ★ 33.51 | N/A |
| EPS | ★ 3.01 | 1.59 |
| Revenue | $4,485,044,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $14.27 | N/A |
| Revenue Next Year | $8.60 | $3.02 |
| P/E Ratio | $124.48 | ★ $115.35 |
| Revenue Growth | ★ 16.26 | 8.24 |
| 52 Week Low | $256.11 | $140.11 |
| 52 Week High | $376.86 | $213.08 |
| Indicator | HEI | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 61.11 | 73.58 |
| Support Level | $317.43 | $163.44 |
| Resistance Level | $373.17 | $187.35 |
| Average True Range (ATR) | 9.10 | 4.00 |
| MACD | 0.61 | 1.04 |
| Stochastic Oscillator | 78.84 | 89.79 |
Heico is an aerospace and defense supplier that focuses on creating replacement parts for commercial aircraft and components for defense products. In commercial aerospace, Heico is the largest independent producer of replacement aircraft parts. In the defense market, the company produces niche subcomponents used in targeting technology as well as simulation equipment, among other categories. It operates two segments: the flight support group and the electronic technologies group. Both supply the aerospace and defense sectors to different degrees. Heico is persistently acquisitive, focusing on companies in similar or adjacent markets that offer strong cash flow and profitable growth potential.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.